Chi E. So

Denmark Hill
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

The transposable element-PARP axis underpins synthetic lethality and immunogenic vulnerability in blood cancer.

The transposable element-PARP axis underpins synthetic lethality and immunogenic vulnerability in blood cancer.

Journal: Blood

Published: December 08, 2025

Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer.

Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer.

Journal: Blood

Published: January 24, 2025

Robotic surgery for bowel endometriosis: a multidisciplinary management of a complex entity.

Robotic surgery for bowel endometriosis: a multidisciplinary management of a complex entity.

Journal: Techniques in coloproctology

Published: October 17, 2023

Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient β-catenin/Hoxa9/Prmt1 axis.

Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient β-catenin/Hoxa9/Prmt1 axis.

Journal: Blood

Published: August 08, 2023

The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.

The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.

Journal: Nature cancer

Published: March 31, 2023

Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML.

Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML.

Journal: Blood

Published: January 23, 2023

A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify®.

A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify®.

Journal: Oncogene

Published: February 02, 2022

KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity.

KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity.

Journal: International journal of oncology

Published: May 23, 2021

Reconstruction of Human AML Using Functionally and Immunophenotypically Defined Human Haematopoietic Stem and Progenitor Cells as Targeted Populations.

Reconstruction of Human AML Using Functionally and Immunophenotypically Defined Human Haematopoietic Stem and Progenitor Cells as Targeted Populations.

Journal: Bio-protocol

Published: May 06, 2021

Therapeutic Opportunities of Targeting Canonical and Noncanonical PcG/TrxG Functions in Acute Myeloid Leukemia.

Therapeutic Opportunities of Targeting Canonical and Noncanonical PcG/TrxG Functions in Acute Myeloid Leukemia.

Journal: Annual review of genomics and human genetics

Published: April 30, 2021

HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia.

HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia.

Journal: Molecular cell

Published: April 19, 2021

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia.

Journal: EMBO molecular medicine

Published: August 09, 2020

Showing 1-12 of 46

Last Updated: 09/26/2026